Cargando…

The economic burden of cancers attributable to smoking in Korea, 2014

INTRODUCTION: Associations between smoking, cancer and mortality are well established. Although cancer mortality rates have decreased in recent years, the economic burden of smoking-related cancers continues to increase. This study investigates the economic costs of cancers related to smoking in Kor...

Descripción completa

Detalles Bibliográficos
Autores principales: Nguyen, Thi Xuan Trinh, Han, Minji, Oh, Jin-Kyoung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Publishing on behalf of the International Society for the Prevention of Tobacco Induced Diseases (ISPTID) 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6751966/
https://www.ncbi.nlm.nih.gov/pubmed/31582926
http://dx.doi.org/10.18332/tid/102673
_version_ 1783452714324197376
author Nguyen, Thi Xuan Trinh
Han, Minji
Oh, Jin-Kyoung
author_facet Nguyen, Thi Xuan Trinh
Han, Minji
Oh, Jin-Kyoung
author_sort Nguyen, Thi Xuan Trinh
collection PubMed
description INTRODUCTION: Associations between smoking, cancer and mortality are well established. Although cancer mortality rates have decreased in recent years, the economic burden of smoking-related cancers continues to increase. This study investigates the economic costs of cancers related to smoking in Korea in 2014. METHODS: Cancer patients were identified through National Health Insurance Services medical claims with ICD-10 cancer codes. We multiplied the costs by the population attributable fraction for each type of cancer and calculated direct and indirect costs, where direct costs comprise direct medical and non-medical costs of inpatients and outpatients, and indirect costs include estimates of future income loss due to premature death, productivity loss during hospitalization and outpatient visits, and job loss. RESULTS: In 2014, there were 79297 smoking-related cancer patients, accounting for 8.47% of all Korean cancer cases for that year. The direct cost of cancers due to smoking was approximately 595 million USD, whereas indirect costs were much higher, at nearly 2.2 billion USD. The average expenditure of a typical patient was 34815 USD. Lung, liver and stomach cancers were most prevalent and represented the most significant share of the economic burden, whereas the largest per-patient spending was for pancreatic, liver, and lung cancers. Lung, liver and stomach cancers had the highest economic impact on men, while lung, liver and ovarian cancers had the most significant economic impact on women. CONCLUSIONS: It is imperative that more stringent steps be taken to reduce the huge economic burden of cancers linked to smoking. ABBREVIATIONS: IARC: International Agency for Research on Cancer, PAF: population attributable fraction, NHIS: National Health Insurance Services, ICD-10: International Statistical Classification of Diseases and Related Health Problem 10th Revision, GDP: Gross Domestic Product, DALYs: Disability-Adjusted-Life-Years, WHO: World Health Organization, FCTC: Framework Convention on Tobacco Control.
format Online
Article
Text
id pubmed-6751966
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher European Publishing on behalf of the International Society for the Prevention of Tobacco Induced Diseases (ISPTID)
record_format MEDLINE/PubMed
spelling pubmed-67519662019-10-03 The economic burden of cancers attributable to smoking in Korea, 2014 Nguyen, Thi Xuan Trinh Han, Minji Oh, Jin-Kyoung Tob Induc Dis Research Paper INTRODUCTION: Associations between smoking, cancer and mortality are well established. Although cancer mortality rates have decreased in recent years, the economic burden of smoking-related cancers continues to increase. This study investigates the economic costs of cancers related to smoking in Korea in 2014. METHODS: Cancer patients were identified through National Health Insurance Services medical claims with ICD-10 cancer codes. We multiplied the costs by the population attributable fraction for each type of cancer and calculated direct and indirect costs, where direct costs comprise direct medical and non-medical costs of inpatients and outpatients, and indirect costs include estimates of future income loss due to premature death, productivity loss during hospitalization and outpatient visits, and job loss. RESULTS: In 2014, there were 79297 smoking-related cancer patients, accounting for 8.47% of all Korean cancer cases for that year. The direct cost of cancers due to smoking was approximately 595 million USD, whereas indirect costs were much higher, at nearly 2.2 billion USD. The average expenditure of a typical patient was 34815 USD. Lung, liver and stomach cancers were most prevalent and represented the most significant share of the economic burden, whereas the largest per-patient spending was for pancreatic, liver, and lung cancers. Lung, liver and stomach cancers had the highest economic impact on men, while lung, liver and ovarian cancers had the most significant economic impact on women. CONCLUSIONS: It is imperative that more stringent steps be taken to reduce the huge economic burden of cancers linked to smoking. ABBREVIATIONS: IARC: International Agency for Research on Cancer, PAF: population attributable fraction, NHIS: National Health Insurance Services, ICD-10: International Statistical Classification of Diseases and Related Health Problem 10th Revision, GDP: Gross Domestic Product, DALYs: Disability-Adjusted-Life-Years, WHO: World Health Organization, FCTC: Framework Convention on Tobacco Control. European Publishing on behalf of the International Society for the Prevention of Tobacco Induced Diseases (ISPTID) 2019-02-28 /pmc/articles/PMC6751966/ /pubmed/31582926 http://dx.doi.org/10.18332/tid/102673 Text en © 2019 Nguyen TXT https://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 International License.
spellingShingle Research Paper
Nguyen, Thi Xuan Trinh
Han, Minji
Oh, Jin-Kyoung
The economic burden of cancers attributable to smoking in Korea, 2014
title The economic burden of cancers attributable to smoking in Korea, 2014
title_full The economic burden of cancers attributable to smoking in Korea, 2014
title_fullStr The economic burden of cancers attributable to smoking in Korea, 2014
title_full_unstemmed The economic burden of cancers attributable to smoking in Korea, 2014
title_short The economic burden of cancers attributable to smoking in Korea, 2014
title_sort economic burden of cancers attributable to smoking in korea, 2014
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6751966/
https://www.ncbi.nlm.nih.gov/pubmed/31582926
http://dx.doi.org/10.18332/tid/102673
work_keys_str_mv AT nguyenthixuantrinh theeconomicburdenofcancersattributabletosmokinginkorea2014
AT hanminji theeconomicburdenofcancersattributabletosmokinginkorea2014
AT ohjinkyoung theeconomicburdenofcancersattributabletosmokinginkorea2014
AT nguyenthixuantrinh economicburdenofcancersattributabletosmokinginkorea2014
AT hanminji economicburdenofcancersattributabletosmokinginkorea2014
AT ohjinkyoung economicburdenofcancersattributabletosmokinginkorea2014